| 5GG | Pentagalloylglucose |
| ABCSG | Austrian breast and colorectal cancer study group |
| AC | Adenocarcinoma |
| c-AMP | Cyclic adenosine monophosphate |
| CCND1 | Cyclin D1 |
| CDC2 kinase | Cell division control 2 kinase |
| CDKs | Cyclin-dependent kinases |
| CI | Confidence interval |
| DC | Ductal carcinoma |
| DCIS | Ductal carcinoma in situ |
| DFS | Disease-free survival |
| DSS | Disease-specific survival |
| E2F1 | E2 promoter factor 1 |
| ER | Estrogen receptor |
| FISH | Fluorescent in situ hybridization |
| GLOBOCAN | Global cancer observatory |
| HDAC3 | Histone deacetylase 3 |
| HER2+ | Human epidermal growth factor receptor2+ |
| HR | Hazard ratio |
| IDC | Invasive ductal carcinoma |
| IHC | Immunohistochemistry |
| ILC | Invasive lobular carcinoma |
| LA | Luminal A |
| MU | Mutation |
| NBE | Normal breast epithelium |
| ND | Not decided |
| OS | Overall survival |
| PD | Proliferative disease |
| PR | Progesterone receptor |
| Rb | Retinoblastoma |
| RFS | Recurrence free survival |
| siRNA | Small interfering RNA |
| TGF-β | Transforming growth factor-β |
| TNBC | Triple negative breast cancer |
| WT | Wild type |